KROS
NASDAQ · Biotechnology

Keros Therapeutics Inc

Biotech Stocks Healthcare Stocks
$11.49
+0.37 (+3.33%)
As of May 9, 1:46 AM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 5 33%
Sell 0 0%
Price Target
Analyst Price Target +71.5% upside
Low Target $13.49
Average Target $19.70
High Target $20.36
Current Price $11.49
Current
$11.49
Target
$19.70
$13.49 $19.70 avg $20.36
Scenario Analysis
Bear Case
$13.49
17.4%
Low target
Base Case
$19.70
+71.5%
Avg target
Bull Case
$20.36
+77.2%
High target
Risk/Reward
4.4x
Highly favorable
Price in Context
52-Week High
$22.55
-49.0% from high
52-Week Low
$10.42
+10.3% from low
Target vs 52W High
$19.70
-12.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%